Timothy Niewold
Director, Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentBarbara Volcker Center for Women and Rheumatic Disease · New York Presbyterian Hospital
- 2005–2007
2001–2004
Research
Immunity · 2018 · 871 citations
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
New England Journal of Medicine · 2018 · 424 citations
High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus
Genes and Immunity · 2007 · First of 5 authors · Corresponding · 339 citations
- JH
49 papers
46 papers
- JM
38 papers
36 papers
36 papers
35 papers
34 papers
34 papers
Grants
- 2011–2029
Translating Oral CD11b Agonist as a Novel Therapeutic for Lupus Nephritis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.2M · University of Texas Med Br Galveston
- 2023–2028
Functional Consequences of Intergenic Autoimmune Disease Risk Variants
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.4M · Hospital for Special Surgery
- 2021–2022
PNP Deficiency and Cytosolic DNA in Lupus Pathogenesis
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $254.3K · New York University School of Medicine
- 2021–2022
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $229.4K · New York University School of Medicine
Clinical trials
- 2026–2030
Safety and Efficacy of ONT01 in Lupus
Site PI · Recruiting · Early phase 1
Hospital for Special Surgery, New York